mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy
Authors
Keywords
-
Journal
PLoS One
Volume 17, Issue 6, Pages e0269951
Publisher
Public Library of Science (PLoS)
Online
2022-06-17
DOI
10.1371/journal.pone.0269951
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Stuffer DNA on the Suppression of Choroidal Neovascularization by a rAAV Expressing a mTOR-Inhibiting shRNA
- (2019) Steven Hyun Seung Lee et al. Molecular Therapy-Methods & Clinical Development
- Role of Inflammation in Diabetic Retinopathy
- (2018) Anne Rübsam et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Diabetic Retinopathy: Pathophysiology and Treatments
- (2018) Wei Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Extended Duration Vascular Endothelial Growth Factor Inhibition in the Eye: Failures, Successes, and Future Possibilities
- (2018) Michael Stewart Pharmaceutics
- ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer
- (2018) Franklin C. Harwood et al. Science Advances
- Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies
- (2018) Michael Whitehead et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Animal models of ocular angiogenesis: from development to pathologies
- (2017) Chi-Hsiu Liu et al. FASEB JOURNAL
- The pathology associated with diabetic retinopathy
- (2017) Judith Lechner et al. VISION RESEARCH
- Neurodegeneration in diabetic retinopathy: Potential for novel therapies
- (2017) Alistair J. Barber et al. VISION RESEARCH
- Panretinal Photocoagulation: A Review of Complications
- (2017) Shivani V. Reddy et al. Seminars in Ophthalmology
- Adeno-Associated Viral Vector-Mediated mTOR Inhibition by Short Hairpin RNA Suppresses Laser-Induced Choroidal Neovascularization
- (2017) Tae Kwann Park et al. Molecular Therapy-Nucleic Acids
- Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1α Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy
- (2016) Jie Wei et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Retinal fibrosis in diabetic retinopathy
- (2016) Sayon Roy et al. EXPERIMENTAL EYE RESEARCH
- Cellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking Experiments
- (2016) Amir Mehdi Ansari et al. Stem Cell Reviews and Reports
- Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory
- (2016) Pedro Romero-Aroca et al. Journal of Diabetes Research
- Cellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking Experiments
- (2016) Amir Mehdi Ansari et al. Stem Cell Reviews and Reports
- Modeling Pulmonary Disease Pathways Using Recombinant Adeno-Associated Virus 6.2
- (2015) Benjamin Strobel et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Temsirolimus Inhibits Proliferation and Migration in Retinal Pigment Epithelial and Endothelial Cells via mTOR Inhibition and Decreases VEGF and PDGF Expression
- (2014) Raffael Liegl et al. PLoS One
- Advances in our understanding of diabetic retinopathy
- (2013) Alan W. Stitt et al. CLINICAL SCIENCE
- Concerted inhibition of HIF-1α and -2α expression markedly suppresses angiogenesis in cultured RPE cells
- (2013) Takeshi Nakajima et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Pathophysiology and treatment of diabetic retinopathy
- (2012) Francesco Bandello et al. ACTA DIABETOLOGICA
- Multispecies-compatible antitumor effects of a cross-species small-interfering RNA against mammalian target of rapamycin
- (2012) Jeonghyun Ahn et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals
- (2012) R. Robinson et al. Disease Models & Mechanisms
- HIF2α Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5
- (2012) Ainara Elorza et al. MOLECULAR CELL
- Emerging Evidence Concerning Systemic Safety of Anti-VEGF Agents – Should Ophthalmologists Be Concerned?
- (2011) Laurence S. Lim et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Muller Cell-Derived VEGF Is Essential for Diabetes-Induced Retinal Inflammation and Vascular Leakage
- (2010) J. Wang et al. DIABETES
- Animal models of choroidal and retinal neovascularization
- (2010) Hans E. Grossniklaus et al. PROGRESS IN RETINAL AND EYE RESEARCH
- A novel program to design siRNAs simultaneously effective to highly variable virus genomes
- (2009) Hui Sun Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer gene therapy using adeno-associated virus vectors
- (2007) Keerang Park Frontiers in Bioscience-Landmark
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search